Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

Table 2

Primary endpoint occurrences.

	ASA n=36	controls n=47
	n (%)	n (%)	p-value (Fisher Exact)
New SBIs	1 (2.8)	6 (12.8)	0.103
Stroke	1 (2.8)	2 (4.3)
TIA	-	1 (2.1)
No CV events	34 (94.4)	38 (80.9)